Sprycel市場，按應用，按年齡層，按配銷通路，按地區

2023年全球Sprycel市場規模為 22.2 億美元，預計到2030年將達到 26.9 億美元，預測期內年複合成長率為 2.8%。

圖 1. Sprycel全球市場佔有率（%），依地區分類，2023年

Sprycel是Dasatinib的品牌名稱，是用於治療某些類型癌症的藥物。Dasatinib屬於一組稱為蛋白酪氨酸激酶抑制劑（TKI）的藥物。Dasatinib透過抑制某些蛋白酪氨酸激酶（參與癌細胞生長和轉移的酵素）的活性發揮作用。 Sprycel是標靶藥物，主要用於治療某些類型的白血病，特別是急性淋巴性白血病（ALL）（Ph+ALL）和慢性骨髓性白血病（CML），其特徵是存在費城染色體。 Sprycel的常見副作用包括疲勞、頭痛、噁心、腹瀉和體液儲存。有些患者可能會出現更嚴重的副作用，例如血球數量減少、肝損傷和出血。醫療保健提供者的密切監測對於管理和解決副作用非常重要。它適用於診斷患有 CML 的成人和 12 個月及以上的兒童。也適用於患有特定亞型急性淋巴細胞白血病（稱為費城染色體陽性或 Ph+ALL）的同一年齡層的成人和兒童。白血病是一種惡性，包括骨髓內發育的未成熟白血球。正常情況下，一旦這些白血球成熟，它們就會進入血液中以抵抗感染疾病並維持人體的免疫系統。

市場動態：

目標適應症的增加、其功效和安全性、適應症的擴展和創新進步是預計在預測期內推動全球Sprycel市場成長的主要因素。癌症研究和治療的進步，包括Sprycel等標靶治療的開發，擴大了醫療保健提供者和患者的選擇範圍。這使得Sprycel擴大採用作為治療方法的一部分。

然而，激烈的競爭、專利到期、監管挑戰、副作用、定價和償付預計將阻礙預測期內全球Sprycel市場的成長。

本研究的主要特點

• 本報告對全球Sprycel市場進行了詳細分析，並介紹了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率。
• 它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
• 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
• 它根據以下參數（例如公司亮點、產品系列、主要亮點、財務表現和策略）對全球Sprycel市場的主要企業進行了介紹。
• 本報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
• 全球Sprycel市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 透過用於分析全球Sprycel市場的各種策略矩陣，將促進相關人員的決策。

目錄：

第1章 研究目的與前提

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

• 市場動態
  • 目標適應症、療效和安全性的普及以及適應症的擴大
  • 激烈的競爭、專利到期和監管挑戰
  • 革命性的進步
• 影響分析
• 主要亮點
• 監管場景
• 產品發布/核准
• PEST分析
• 波特的分析
• 併購場景

第4章 全球Sprycel市場 – 冠狀冠狀病毒（COVID-19）大流行的影響

• 新型冠狀病毒感染疾病（COVID-19）的流行病學
• 供需面分析
• 經濟影響

第5章 全球Sprycel市場，依應用分類，2018-2030年

• 慢性骨髓性白血病（CML）
• 費城染色體陽性急性淋巴性白血病（Ph+ALL）

第6章 全球Sprycel市場，依年齡分類，2018-2030

• 成年患者
• 兒童患者

第7章 全球Sprycel市場，依配銷通路，2018-2030

• 醫院和診所
• 零售藥房
• 網路藥房
• 專業藥房

第8章 全球Sprycel市場，依地區，2018-2030年

• 北美洲
• 美國
• 加拿大
• 歐洲
• 英國
• 德國
• 義大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 中國
• 印度
• 日本
• ASEAN
• 澳洲
• 韓國
• 其他亞太地區
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 中東
• GCC
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中部非洲
• 南非

第9章 競爭形勢

• Bristol-Myers Squibb（BMS）

第10章

• 調查方法
• 關於出版商

The global Sprycel market size is estimated to be valued at US$ 2.22 billion in 2023 and is projected to reach US$ 2.69 billion by 2030, growing at a CAGR of 2.8% during the forecast period.

Figure 1. Global Sprycel Market Share (%), by Region, 2023

Sprycel is the brand name for dasatinib, a medication used in the treatment of certain types of cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs). Dasatinib works by inhibiting the activity of specific tyrosine kinases, which are enzymes involved in the growth and spread of cancer cells. Sprycel is a targeted medication primarily employed in the treatment of certain types of leukemia, specifically acute lymphoblastic leukemia (ALL), characterized by the presence of the Philadelphia chromosome (Ph+ ALL), and chronic myeloid leukemia (CML). Common side effects of Sprycel may include fatigue, headache, nausea, diarrhea, and fluid retention. Some patients may also experience more serious side effects, such as low blood cell counts, liver problems, and bleeding. Close monitoring by healthcare providers is important to manage and address any adverse effects. It is administered to both adults and children aged 12 months and older who are diagnosed with CML. Additionally, it is prescribed for adults and children in the same age group who are afflicted with a specific subtype of acute lymphoblastic leukemia known as Philadelphia chromosome-positive or Ph+ ALL. Leukemia is a malignancy involving immature white blood cells that develop within the bone marrow. In the normal course of events, as these white blood cells mature, they enter the bloodstream to combat infections and maintain the body's immune system.

Market Dynamics:

The increasing prevalence of targeted indications, their efficacy and safety profile, expanded indications, and innovative advancements are major factors expected to drive growth of the global sprycel market during the forecast period. Advancements in cancer research and treatment, including the development of targeted therapies like Sprycel, have expanded the options available to healthcare providers and patients. This has led to increased adoption of Sprycel as part of the treatment regimen.

However, strong competition, patent expiration, regulatory challenges, adverse effects, and pricing and reimbursement are expected to hamper the growth of the global Sprycel market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global Sprycel market, and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Sprycel market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bristol-Myers Squibb (BMS)
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Sprycel market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Sprycel market

Detailed Segmentation:

• By Application:
  • Chronic myeloid leukemia (CML)
  • Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
• By Age Group:
  • Adult Patients
  • Pediatric Patients
• By Distribution Channel:
  • Hospitals and Clinics
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• By Company Profiles:
  • Bristol-Myers Squibb (BMS)

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Global Sprycel, By Application
  • Market Global Sprycel, By Age Group
  • Market Global Sprycel, By Distribution Channel
  • Market Global Sprycel, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing prevalence of targeted indications, efficacy and safety profile, expanded indications
  • Strong competition, patent expiration, regulatory challenges
  • Innovative advancements
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Sprycel Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Sprycel Market, By Application, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Chronic myeloid leukemia (CML)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Sprycel Market, By Age Group, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Adult Patients
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Pediatric Patients
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Sprycel Market, By Distribution Channel, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Specialty Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Sprycel Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Bristol-Myers Squibb (BMS)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us